Agilent Technologies Inc vs iShares 1 3 Year Treasury Bond ETF — how do they compare? Agilent Technologies Inc trades at $149.35 (market cap $42.00B), while iShares 1 3 Year Treasury Bond ETF trades at $81.9. The key difference: Agilent Technologies Inc pays a 0.69% dividend while iShares 1 3 Year Treasury Bond ETF pays none, and Agilent Technologies Inc is trading nearer its 52-week high, iShares 1 3 Year Treasury Bond ETF nearer its low. Which is the better fit depends on your goals.
| A | SHY | |
|---|---|---|
Market Cap | $42.00B | — |
Sector | Health | Fixed Income |
52-Week High | $157.20 | $83.18 |
52-Week Low | $110.24 | $81.77 |
Enterprise Value | $43.55B | — |
Dividend Yield | 0.69% | — |
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $145.97, up 3.28% in the last session, with a bullish technical outlook from moving averages but overbought RSI levels. The company reported strong Q1 2026 earnings, beating estimates with EPS of $1.49, and maintains solid profitability with a net income margin of 19.55%. Recent developments include FDA and EU approvals for diagnostic assays and the acquisition of Biocare Medical, enhancing its healthcare portfolio.
The stock offers upside to the consensus price target of $154.90, supported by analyst optimism (77.5% buy ratings), but high valuation ratios like a P/E of 146.56 pose risks. Investors should monitor execution of growth initiatives and competitive pressures in the life sciences sector, with earnings on August 26, 2026, as a key catalyst.
SHY, the iShares 1-3 Year Treasury Bond ETF, trades at $81.92, up 0.15% on the day, with a bearish technical bias as moving averages signal selling pressure. Recent news highlights institutional accumulation amid rising Treasury yields and inflation concerns, while dividend distributions remain steady.
The outlook is cautious due to interest rate uncertainty and geopolitical tensions affecting bond markets. Risks include Fed policy shifts and oil price volatility, but SHY offers stability for income-focused investors seeking short-term Treasury exposure.
Trailing returns across standard periods
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →SHY provides exposure to U.S. Treasury bonds with remaining maturities between one and three years. It is a low-risk, highly liquid ETF designed for capital preservation and short-term income, featuring 2026 top holdings across various Treasury Notes.
Read more on SHY →